If you made any changes in Pure these will be visible here soon.

Research Output 1989 2019

Filter
Patent
2018

Compounds and their use as PDE4 activators

Adam, J. M. & Adams, D. R., 5 Apr 2018, IPC No. A61K31/4196, A61P1/00, A61P11/00, A61P13/00, A61P35/00, A61P5/00, A61P9/00, C07D249/08, C07D403/12, World Intellectual Property Organization (WIPO), Patent No. WO2018060704(A1), Priority date 28 Sep 2016, Priority No. GB20160016439 20160928

Research output: Patent

Open Access
File
Type 4 Cyclic Nucleotide Phosphodiesterase
Cyclic Nucleotides
Second Messenger Systems
Cyclic AMP
Protein Isoforms
2016

Pro-survival Compounds

Mountford, J., Milligan, G. & Adams, D. R., 16 Jun 2016, IPC No. A61K31/4184, C07D233/54, C07D233/66, Patent No. WO2016092327A1, Priority date 11 Dec 2014

Research output: Patent

File
Stem Cells
Cell Culture Techniques
Maintenance
In Vitro Techniques
2011

Stem cell culture methods

Adams, D., Burton, P., Houslay, M. D., Milligan, G. & Mountford, J. C., 30 Nov 2011, IPC No. C12N5/0735, Patent No. EP2389436 A2

Research output: Patent

2010

Pyrazolopyridine-4-Yl Pyridazinone Derivatives and Addition Salts Thereof, and PDE Inhibitors Comprising the Same Derivatives or Salts as Active Ingredient

Kohno, Y., Adams, D. & Ando, N., 27 Jul 2010, IPC No. A61K31/501; A61P11/06; A61P25/24; A61P29/00; A61P33/08; C07D401/14; C07D403/14, Patent No. US7763617(B2)

Research output: Patent

Salts
Derivatives
Phosphodiesterase Inhibitors
Patents and inventions
Pharmaceutical Preparations

Stem cell culture methods

Adams, D., Burton, P., Houslay, M. D., Milligan, G. & Mountford, J. C., 16 Sep 2010, IPC No. C12N5/0735, Patent No. WO2010084300(A3)

Research output: Patent

Stem cell culture methods

Adams, D., Burton, P., Houslay, M. D., Milligan, G. & Mountford, J. C., 29 Jul 2010, IPC No. C12N5/0735, Patent No. WO2010084300 A2

Research output: Patent

2008

2-SUBSTITUTED-6-(PYRAZOLOPYRIDIN-3-YL)PYRIDAZINONE DERIVATIVE, ADDUCT SALT OF THE SAME AND PDE INHIBITOR BY USING THEM AS ACTIVE INGREDIENT

Translated title of the contribution: 2-SUBSTITUTED-6-(PYRAZOLOPYRIDIN-3-YL)PYRIDAZINONE DERIVATIVE, ADDUCT SALT OF THE SAME AND PDE INHIBITOR BY USING THEM AS ACTIVE INGREDIENT Kono, Y. & Adams, D., 9 Oct 2008, IPC No. A61K31/501; A61P1/04; A61P11/06; A61P15/10; A61P17/00; A61P25/00; A61P25/14; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P29/00; A61P37/08; A61P43/00; A61P9/04; A61P9/10; A61P9/12; C07D471/04, Patent No. JP2008239558(A)

Research output: Patent

Phosphodiesterase Inhibitors
Salts
Derivatives
Phosphoric Diester Hydrolases
Medicine

Pyrazolopyridine-4-Yl Pyridazinone Derivatives and Addition Salts Thereof, and Pde Inhibitors Comprising the Same Derivatives or Salts as Active Ingredient

Kohno, Y., Adams, D. & Ando, N., 28 Aug 2008, IPC No. A61P11/06; A61P15/00; A61P25/00; A61P29/00; A61P37/08; A61P43/00; A61P7/02; A61P9/00; C07D401/14, Patent No. US2008207902(A1)

Research output: Patent

PYRIDAZINONE DERIVATIVE AND PDE INHIBITOR COMPRISING THE SAME AS ACTIVE INGREDIENT

Translated title of the contribution: PYRIDAZINONE DERIVATIVE AND PDE INHIBITOR COMPRISING THE SAME AS ACTIVE INGREDIENTKono, Y. & Adams, D., 21 Mar 2008, IPC No. A61K31/501; A61P1/04; A61P11/00; A61P11/02; A61P11/06; A61P15/10; A61P17/02; A61P19/02; A61P25/00; A61P25/14; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P29/00; A61P3/04; A61P3/06; A61P3/10; A61P37/08; A61P43/00; A61P7/02; A61P9/04; A61P9/10; A61P9/12; C07D403/04; C07D413/04; C07D417/04, Patent No. JP2008063265(A)

Research output: Patent

Phosphodiesterase Inhibitors
Benzoxazoles
Derivatives
Phosphoric Diester Hydrolases
Hydrates
2006

PYRAZOLOPYRIDINE-4-YL PYRIDAZINONE DERIVATIVE AND ADDITION SALT THEREOF, AND PDE INHIBITOR COMPRISING THE DERIVATIVE OR SALT AS ACTIVE INGREDIENT

Kohno, Y., Adams, D. & Ando, N., 14 Sep 2006, IPC No. A61K31/501; A61K31/5377; A61P11/06; A61P15/00; A61P25/00; A61P29/00; A61P37/08; A61P43/00; A61P7/02; A61P9/00; C07D471/04, Patent No. WO2006095666(A1)

Research output: Patent